Michael M Lieberman

Summary

Affiliation: Hawaii Biotech
Country: USA

Publications

  1. doi Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser)
    Susan I Jarvi
    Department of Biology, College of Arts and Sciences and Department of Pharmaceutical Sciences, College of Pharmacy, University of Hawai i at Hilo, 200 West Kawili Street, Hilo, HI 96720, USA
    Vaccine 26:5338-44. 2008
  2. pmc Preparation and immunogenic properties of a recombinant West Nile subunit vaccine
    Michael M Lieberman
    Hawaii Biotech, Inc, 99 193 Aiea Heights Drive, Aiea, HI 96701, USA
    Vaccine 25:414-23. 2007
  3. pmc Use of hollow fiber systems for rapid and direct scale up of antibody production from hybridoma cell lines cultured in CL-1000 flasks using BD Cell MAb medium
    Michael J Gramer
    BioVest International, Inc, 8500 Evergreen Boulevard, Minneapolis, MN, 55433, USA E mail
    Cytotechnology 42:155-62. 2003
  4. pmc Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys
    David E Clements
    Hawaii Biotech, Inc, 99 193 Aiea Heights Drive, Aiea, HI 96701, United States
    Vaccine 28:2705-15. 2010
  5. pmc Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys
    Michael M Lieberman
    Hawaii Biotech, Inc, Aiea, HI 96701, USA
    Clin Vaccine Immunol 16:1332-7. 2009
  6. pmc Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis
    Douglas M Watts
    University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77551, USA
    Vaccine 25:2913-8. 2007

Collaborators

Detail Information

Publications6

  1. doi Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser)
    Susan I Jarvi
    Department of Biology, College of Arts and Sciences and Department of Pharmaceutical Sciences, College of Pharmacy, University of Hawai i at Hilo, 200 West Kawili Street, Hilo, HI 96720, USA
    Vaccine 26:5338-44. 2008
    ..Safe and effective vaccination of managed or captive endangered bird populations will protect species with critically low numbers that could not survive the added mortality of introduced disease...
  2. pmc Preparation and immunogenic properties of a recombinant West Nile subunit vaccine
    Michael M Lieberman
    Hawaii Biotech, Inc, 99 193 Aiea Heights Drive, Aiea, HI 96701, USA
    Vaccine 25:414-23. 2007
    ..These findings are encouraging and warrant further in vivo studies to determine the protective efficacy of the WNV vaccine candidate...
  3. pmc Use of hollow fiber systems for rapid and direct scale up of antibody production from hybridoma cell lines cultured in CL-1000 flasks using BD Cell MAb medium
    Michael J Gramer
    BioVest International, Inc, 8500 Evergreen Boulevard, Minneapolis, MN, 55433, USA E mail
    Cytotechnology 42:155-62. 2003
    ..In summary, these results demonstrate successful scale up of antibody production from the CL-1000 to a hollow fiber system...
  4. pmc Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys
    David E Clements
    Hawaii Biotech, Inc, 99 193 Aiea Heights Drive, Aiea, HI 96701, United States
    Vaccine 28:2705-15. 2010
    ..These results support the development of a dengue virus tetravalent vaccine based on the four 80E subunits produced in the Drosophila S2 cell expression system...
  5. pmc Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys
    Michael M Lieberman
    Hawaii Biotech, Inc, Aiea, HI 96701, USA
    Clin Vaccine Immunol 16:1332-7. 2009
    ..Thus, the WN-80E vaccine was 100% efficacious in protecting monkeys against infection with WNV...
  6. pmc Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis
    Douglas M Watts
    University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77551, USA
    Vaccine 25:2913-8. 2007
    ..These results with the recombinant subunit WNV vaccine are very encouraging and warrant further animal studies to evaluate its potential use to protect humans against WNV disease...